MARCHF9 and colorectal carcinoma: In summary, our results confirmed that MARCH9 was overexpressed in CRC patients and its overexpression contributed to the proliferation, migration and tumorigenesis of CRC cells, suggesting that it may function as an oncogene during this disease.